BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.70 +0.11 (+7.71%)
As of: Aug 21, 2026 · 9:30 AM EDT

BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023)

BioNexus Gene Lab (BGLC) posted Deferred Taxes of $15990.0 for Q2 2023, up 886.43% sequentially from $1621.0 in Q2 2022, and up 886.43% YoY from $1621.0 in Q2 2022.

BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023) Analysis & Trends

BioNexus Gene Lab has reported Deferred Taxes for 2 years, with the latest figure at $15990.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Linde 223.26 Bn 218.36 Bn 4.43 Bn -20.00 Mn
2 Sherwin Williams 84.42 Bn 84.13 Bn 3.34 Bn -7.70 Mn
3 Ecolab 78.60 Bn 73.46 Bn 1.95 Bn -
4 Air Products & Chemicals 66.89 Bn 65.91 Bn 1.04 Bn -637.30 Mn
5 Ppg Industries 25.12 Bn 23.52 Bn 1.81 Bn -44.00 Mn
6 Chemical & Mining Co Of Chile 24.04 Bn 20.17 Bn 778.60 Mn -
7 LyondellBasell Industries 22.09 Bn 19.46 Bn 2.04 Bn -68.00 Mn
8 International Flavors & Fragrances 21.50 Bn 20.94 Bn 853.00 Mn -22.00 Mn
9 DuPont de Nemours 19.06 Bn 17.32 Bn 639.00 Mn 57.00 Mn
10 BioNexus Gene Lab 2.43 Mn -1.10 Mn 12,982.00 -

Historic Data

Download Data
DateValue
Jun 30, 2023 15,990.00
Jun 30, 2022 1,621.00